Inflammatory profile in LRRK2-associated prodromal and clinical PD
Kathrin Brockmann(Oregon Health & Science University), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Claustre Pont‐Sunyer(Hospital Clínic de Barcelona), J.F. Martí-Massó, Nicole Schneiderhan‐Marra(Natural and Medical Sciences Institute), Florence Cormier(Sorbonne Université), Alexis Brice(School of the Art Institute of Chicago), Jan Aasly(Norwegian University of Science and Technology), Tatiana Foroud, Javier Ruiz‐Martínez(Instituto de Salud Carlos III), Markus Langkamp(Immundiagnostik (Germany)), Thomas Gasser(Hertie Institute for Clinical Brain Research), Connie Marras(University of Toronto), Claudia Schulte(School of the Art Institute of Chicago), Eduardo Tolosa(Biomedical Research Networking Center on Neurodegenerative Diseases), Thomas Joos(University of Tübingen), Dolores Vilas(Centre Hospitalier Universitaire de Lille), Thomas Knorpp(University of Tübingen), Anja Apel(University of Basel), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Birgitt Schüle(Chan Zuckerberg Initiative (United States)), Jean‐Christophe Corvol(Centre National de la Recherche Scientifique)
Cited by 78
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k